Iron deficiency anemia after cardiac surgery: is there an added value of therapy with sucrosomial iron on top on ferric carboxymaltose? Preliminary data
Anno:
2024
Background: IDA after CS increases mortality, serious adverse events and length of stay; it also has a negative impact on the cardiac rehabilitation (CR) program. The FCM is the gold standard for IDA patients (P). However short-term treatment of IDA after CS using FMC or SI showed a significant…